EPICS Therapeutics
PrivateLast Round
VC Round
Sep 22, 2025
Total Funding Raised
$37.54M
Company Overview
EPICS Therapeutics is a biotechnology company that develops small molecule drugs targeting RNA epigenetic mechanisms for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EPICS Therapeutics Comparables
Compare EPICS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STORM Therapeutics | 90% | |
| Accent Therapeutics | 87% | |
| 858 Therapeutics | 79% | |
EPICS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2025 | ||||
| Series A Extension | Oct 18, 2024 | ||||
| Series A | Dec 31, 2018 | ||||
| Seed | May 24, 2018 |
EPICS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | VC Round, Series A, Series A Extension |
| Newton Biocapital | Series A, Seed, VC Round, Series A Extension |
| Fund+ | VC Round, Series A, Series A Extension |
| Société Régionale d'Investissement de Wallonie | Seed, Series A |
| Investsud | Seed |
| Wallonie Entreprendre | Seed, VC Round, Series A Extension |
| Theodorus | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 18, 2024
$13M round led by Newton Biocapital.
- May 24, 2018
$8.4M round led by Newton Biocapital
EPICS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EPICS Therapeutics's valuation, stock price, and market status.